| Application number | Title of the application | Filing Date | Status |
|---|
| 09/663702 | ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THAT BIND IP-10/MIG RECEPTOR DESIGNATED CXCR3 AND METHODS OF USE THEREFOR | Sep 14, 2000 | Abandoned |
Array
(
[id] => 1366761
[patent_doc_number] => 06562347
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-13
[patent_title] => 'Chemokine-tumor antigen fusion proteins as cancer vaccines'
[patent_app_type] => B1
[patent_app_number] => 09/646028
[patent_app_country] => US
[patent_app_date] => 2000-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41891
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/562/06562347.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646028
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646028 | Chemokine-tumor antigen fusion proteins as cancer vaccines | Sep 11, 2000 | Issued |
| 09/656927 | Novel uses of mammalian CCR6 receptors and related reagents | Sep 6, 2000 | Abandoned |
Array
(
[id] => 7643737
[patent_doc_number] => 06429303
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-06
[patent_title] => 'Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same'
[patent_app_type] => B1
[patent_app_number] => 09/651200
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 5
[patent_no_of_words] => 43058
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/429/06429303.pdf
[firstpage_image] =>[orig_patent_app_number] => 09651200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/651200 | Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same | Aug 29, 2000 | Issued |
Array
(
[id] => 1106637
[patent_doc_number] => 06808710
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-26
[patent_title] => 'Downmodulating an immune response with multivalent antibodies to PD-1'
[patent_app_type] => B1
[patent_app_number] => 09/645069
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 69
[patent_no_of_words] => 57994
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/808/06808710.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645069
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645069 | Downmodulating an immune response with multivalent antibodies to PD-1 | Aug 22, 2000 | Issued |
| 09/643595 | Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis | Aug 21, 2000 | Abandoned |
Array
(
[id] => 1308054
[patent_doc_number] => 06613327
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-02
[patent_title] => 'Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal'
[patent_app_type] => B1
[patent_app_number] => 09/628129
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 31
[patent_no_of_words] => 22920
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/613/06613327.pdf
[firstpage_image] =>[orig_patent_app_number] => 09628129
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628129 | Methods of preventing immune-mediated abortion by inhibiting a CD28-mediated costimulatory signal | Jul 27, 2000 | Issued |
Array
(
[id] => 7631182
[patent_doc_number] => 06635750
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'B7-H2 nucleic acids, members of the B7 family'
[patent_app_type] => B1
[patent_app_number] => 09/620461
[patent_app_country] => US
[patent_app_date] => 2000-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 41
[patent_no_of_words] => 46404
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635750.pdf
[firstpage_image] =>[orig_patent_app_number] => 09620461
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/620461 | B7-H2 nucleic acids, members of the B7 family | Jul 19, 2000 | Issued |
| 09/530237 | INDUCER FOR PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY, EXPRESSION VECTOR CONTAINING GENE THEREFOR, AND METHOD OF INDUCING PRODUCTION OF ANTIGEN-SPECIFIC ANTIBODY | Jul 11, 2000 | Abandoned |
Array
(
[id] => 1486073
[patent_doc_number] => 06365716
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Antibodies to lipocalin homologs'
[patent_app_type] => B1
[patent_app_number] => 09/614022
[patent_app_country] => US
[patent_app_date] => 2000-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24533
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365716.pdf
[firstpage_image] =>[orig_patent_app_number] => 09614022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/614022 | Antibodies to lipocalin homologs | Jul 10, 2000 | Issued |
| 09/596387 | Autologous adoptive immunotherapy with antigen-specific primed T cells or B cells to promote antigen-specific immune responses with an appropriate cytokine bias | Jun 15, 2000 | Abandoned |
| 09/591543 | AN INTEGRIN BETA -SUBUNIT AND USES THEREOF | Jun 7, 2000 | Abandoned |
| 09/589668 | Sialoadhesin family member-2 (SAF-2) | Jun 6, 2000 | Abandoned |
| 60/287576 | Soluble CTLA4 mutant molecules and uses thereof | May 25, 2000 | Pending |
| 09/574100 | Novel IL-9/IL-2 receptor-like molecules and uses thereof | May 17, 2000 | Abandoned |
| 09/446069 | TOPICAL TREATMENT OF PSORIASIS USING NEUTRALIZING ANTIBODIES TO IL-8 | May 11, 2000 | Issued |
Array
(
[id] => 1500078
[patent_doc_number] => 06485970
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'Immunointeractive antibody'
[patent_app_type] => B1
[patent_app_number] => 09/508701
[patent_app_country] => US
[patent_app_date] => 2000-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 61
[patent_no_of_words] => 23802
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/485/06485970.pdf
[firstpage_image] =>[orig_patent_app_number] => 09508701
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/508701 | Immunointeractive antibody | May 9, 2000 | Issued |
Array
(
[id] => 1564346
[patent_doc_number] => 06338851
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein'
[patent_app_type] => B1
[patent_app_number] => 09/570367
[patent_app_country] => US
[patent_app_date] => 2000-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 20
[patent_no_of_words] => 29338
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/338/06338851.pdf
[firstpage_image] =>[orig_patent_app_number] => 09570367
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/570367 | Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein | May 4, 2000 | Issued |
Array
(
[id] => 4275013
[patent_doc_number] => 06323334
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Nucleic acid molecules encoding a 103 gene product and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/560639
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 67
[patent_no_of_words] => 67818
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323334.pdf
[firstpage_image] =>[orig_patent_app_number] => 560639
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/560639 | Nucleic acid molecules encoding a 103 gene product and uses therefor | Apr 27, 2000 | Issued |
| 09/561533 | NUCLEIC ACIDS EXPRESSED IN HUMAN ACTIVATED T-LYMPHOCYTES AND METHODS OF USING THE SAME | Apr 27, 2000 | Abandoned |
